RYTM (STOCKS)
Rhythm Pharmaceuticals, Inc. Common Stock
$89.700000
+1.320000 (+1.49%)
Prev close: $88.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David P. Meeker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,167.94M
- Employees
- 283
- P/E (TTM)
- -28.59
- P/B (TTM)
- 49.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
12
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.83 | $-0.87 | +0.0397 | +4.56% |
|
Dec 2025 (Q4)
|
$-0.73 | $-0.84 | +0.1080 | +12.89% |
|
Sep 2025 (Q3)
|
$-0.82 | $-0.74 | -0.0816 | -11.05% |
|
Jun 2025 (Q2)
|
$-0.75 | $-0.69 | -0.0609 | -8.84% |
Financial Statements
| Revenues | $217.17M |
| Benefits Costs and Expenses | $418.88M |
| Cost Of Revenue | $23.00M |
| Costs And Expenses | $414.54M |
| Gross Profit | $194.16M |
| Nonoperating Income/Loss | -$4.35M |
| Operating Expenses | $391.54M |
| Selling, General, and Administrative Expenses | $219.44M |
| Research and Development | $172.09M |
| Operating Income/Loss | -$197.37M |
| Income/Loss From Continuing Operations After Tax | -$202.68M |
| Income/Loss From Continuing Operations Before Tax | -$201.72M |
| Income Tax Expense/Benefit | $962.00K |
| Net Income/Loss | -$202.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$202.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$207.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $3.81M |
| Preferred Stock Dividends And Other Adjustments | $3.81M |
| Basic Earnings Per Share | -$3.13 |
| Diluted Earnings Per Share | -$3.13 |
| Basic Average Shares | 198,557,380 |
| Diluted Average Shares | 198,557,380 |
| Assets | $442.32M |
| Current Assets | $430.09M |
| Cash | $340.60M |
| Inventory | $28.65M |
| Other Current Assets | $60.84M |
| Noncurrent Assets | $12.23M |
| Fixed Assets | $1.07M |
| Other Non-current Assets | $11.16M |
| Liabilities | $204.70M |
| Current Liabilities | $103.20M |
| Accounts Payable | $12.30M |
| Other Current Liabilities | $90.90M |
| Noncurrent Liabilities | $101.50M |
| Equity | $122.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $122.91M |
| Temporary Equity | $114.71M |
| Temporary Equity Attributable To Parent | $114.71M |
| Liabilities And Equity | $442.32M |
| Net Cash Flow From Operating Activities | -$119.51M |
| Net Cash Flow From Operating Activities, Continuing | -$119.51M |
| Net Cash Flow From Investing Activities | -$104.91M |
| Net Cash Flow From Investing Activities, Continuing | -$104.91M |
| Net Cash Flow From Financing Activities | $180.06M |
| Net Cash Flow From Financing Activities, Continuing | $180.06M |
| Net Cash Flow | -$44.36M |
| Net Cash Flow, Continuing | -$44.36M |
| Comprehensive Income/Loss | -$202.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$206.24M |
| Other Comprehensive Income/Loss | -$52.92M |